Pharmaceutical Business review

Iomai stockholders approve merger with Intercell subsidiary

Approximately 71.6% of Iomai’s outstanding shares entitled to vote at the special meeting approved the merger, representing approximately 99.9% of the votes cast.

The transaction remains subject to certain closing conditions. Assuming satisfaction of the remaining conditions, the transaction is anticipated to be completed on or about August 5, 2008.

Exit mobile version